Align for the future with next gen Myval transcatheter heart valve series

Sponsored by Meril Life Sciences

Anchorperson: A. Seth

Spokesperson: O. De Backer

Summary

Discover how the latest Myval transcatheter heart valve (THV) innovations are shaping TAVI outcomes. This PCR London Valves 2025 session highlights the clinical evidence behind the next-gen Myval THV series, best practices for implantation, and upcoming innovations set to improve patient care. Learn step-by-step techniques for deploying Myval Octapro + in challenging anatomies, how the large size matrix and OctaAlign method optimise results, and how the growing Myval portfolio is addressing diverse patient profiles. A practical guide to elevating your structural heart interventions with precision and confidence.

Learning Objectives

To be updated about the clinical evidence from Myval THV series
To learn the best practices for optimal implantation of next gen Myval THV series
To know about upcoming innovations which should impact patient outcomes for TAVI procedures